RPT-Whiplashed investors stay skittish about St. Jude

Aug 26 (Reuters) - One day after a short seller claimed that St. Jude Medical Inc's heart implants are vulnerable to deadly cyber attacks, investors appear most concerned about whether the accusation will derail St. Jude's $24 billion planned deal for Abbott Labs to buy it.